You know what else is a failure? Your sad attempt to scare me out of this stock. I don't take advice from 10 cents per post message board bashers.
Sentiment: Strong Buy
The drug was a complete bust in the LI-1 trial. It couldnt even beat LoDAC as monotherapy, nor was the combo of Vosaroxin + LoDAC better than LoDAC by itself. The bar to move forward was quite low as well, only need to have 10% higher CR rate than LoDAC.
I applaud their honestly throughout, but this will not work. Look up Antisoma - claimed similar stuff about their drug and it failed pretty miserably.
Sentiment: Strong Sell
Its a double blind. If that happened, then the final say would not be credible. tsk tsk tsk
There is not a lot of calls getting written. Premiums are sky high!
to 7.50 + and do a stock grab. Many covered shares will be ~~GRABBED~~
UBS warned you. 24+++
well, they may have 300% gains so you cannot blame them too much. Market was looking frail for a moment. Mr. Market may have more gains in store! Today looks good.
Yeah, the close should be above 7.75 per the chart. Do the math. Its a fibbernacho with cheese.
The ask was $ 200,000 a share. Why don't you just cover your 100 share short at market and suck it in?
Trials have failed
insiders are dumping, UBS upgrade was played out so that funds can sell
This will see 1.5
DO NOT hold this
Agree with your logic. Disagree any combination of chemo will ever represent a cure. BMT is the potential cure for this condition. Time is all that drugs can buy, and there certainly is a price associated with the drugs. The quicksilver upside I see is how easy the sale of the drug can be, once FDA approves and recommends the combination to the oncology community. Its an instant sale if the results warrant the use. Plain and simple. And yes, the company becomes a take-over target. Again, with strong positive results.
Only three more trading days to go until option expiration... I have a large short Sept $4 put position... But see a huge open interest volume on the $5 puts. It's almost like a game of chicken... But at $7 for last trading price, I'm not swerving yet.